Researchers have produced a review of chromatography media and purification processes for handling complex and super-large ...
Labomatic Instruments and Knauer recently announced a new strategic cooperative relationship to offer their instrument portfolios to each other’s customer bases.
The following is a message from FDA: On January 21, 2025, the Food and Drug Administration approved treosulfan (Grafapex, medac GmbH), an alkylating agent, with fludarabine as a preparative regimen ...
1 天
But Why Tho? on MSNREVIEW: ‘Universal Language (2025)’ Is An Exquisite Marriage Of Film TraditionsWith deep influences from the French and Iranian New Waves, Universal Language is equal parts a moving experience and a ...
The Spring Festival Golden Week will begin next Tuesday (28 February) for a stretch of eight days (28 January – 4 February). Macao Government Tourism Office (MGTO) has been carrying out a variety of ...
Treosulfan (Grafapex) was approved in Canada in June 2021 for the same use and is marketed under the brand name Trecondyv.
5 天
AZoM on MSNRevolutionizing Mineral Analysis: The Launch of AZtecGeoAZtecGeo is a geoscience-dedicated user profile for particle analysis software AZtecFeature, designed to guide the automated ...
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...
Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and ...
The Food and Drug Administration (FDA) has approved Grafapex ™ (treosulfan) for injection with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果